Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02213042. IPD Sharing: YES. Countries: 12. Publications: 0.
Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry Study
ClinicalTrials.gov study NCT02393924. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors
ClinicalTrials.gov study NCT02881190. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study to Evaluate SHR6390 Combined With Pyrotinib in Patients With HER2 Positive Gastric Cancer
ClinicalTrials.gov study NCT03480256. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant
ClinicalTrials.gov study NCT04899349. IPD Sharing: YES. Countries: 2. Publications: 0.
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT01547741. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
ClinicalTrials.gov study NCT01423123. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
ClinicalTrials.gov study NCT05207709. IPD Sharing: NO. Countries: 3. Publications: 1.
Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
ClinicalTrials.gov study NCT00820547. IPD Sharing: YES. Countries: 1. Publications: 1.
Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer
ClinicalTrials.gov study NCT02004769. IPD Sharing: YES. Countries: 1. Publications: 4.
A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT03989037. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT02568839. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)
ClinicalTrials.gov study NCT00550771. IPD Sharing: YES. Countries: 0. Publications: 1.
A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer
ClinicalTrials.gov study NCT00058526. IPD Sharing: Not stated. Countries: 5. Publications: 1.
AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer
ClinicalTrials.gov study NCT04499118. IPD Sharing: NO. Countries: 1. Publications: 1.
Observation of Medical Treatments in MBC HER2-negative Patients
ClinicalTrials.gov study NCT02365831. IPD Sharing: NO. Countries: 1. Publications: 14.
Dual Anti-HER2 Therapy (Lapatinib and Trastuzumab) Plus Chemotherapy in HER2-positive MBC
ClinicalTrials.gov study NCT04001634. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma
ClinicalTrials.gov study NCT02884453. IPD Sharing: NO. Countries: 1. Publications: 2.
Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis
ClinicalTrials.gov study NCT02632201. IPD Sharing: Not stated. Countries: 1. Publications: 26.
Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
ClinicalTrials.gov study NCT06462092. IPD Sharing: YES. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.